Cargando…
Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines
Autores principales: | Kohler, Jillian C., Mackey, Tim K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315687/ https://www.ncbi.nlm.nih.gov/pubmed/32586387 http://dx.doi.org/10.1186/s12916-020-01661-3 |
Ejemplares similares
-
Four actions Australia should take to advance equitable global access to COVID‐19 vaccines
por: Gleeson, Deborah, et al.
Publicado: (2022) -
Call to action for equitable access to human milk for vulnerable infants
por: Israel-Ballard, Kiersten, et al.
Publicado: (2019) -
Call to Action for Advancing Equitable Genomic Newborn Screening
por: Ersig, Anne L., et al.
Publicado: (2023) -
A call to action: A need for initiatives that increase equitable access to COVID-19 therapeutics
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2022) -
A call for a moratorium on the .health generic top-level domain: preventing the commercialization and exclusive control of online health information
por: Mackey, Tim K, et al.
Publicado: (2014)